GLP-1 medications like semaglutide (Ozempic/Wegovy), liraglutide, dulaglutide, and others have become some of the most popular treatments for type 2 diabetes and weight loss. Millions of people now use these medicines every month. Because so many adults are starting GLP-1 drugs, it is more important than ever to understand their possible risks and side effects, not...
A Simple Nasal Spray Being Tested for More Than Allergies Scientists have recently become interested in a common nasal spray used for allergies because early lab studies showed that it might also help stop viruses, including the virus that causes COVID-19, from entering the body.A new clinical trial published in JAMA Internal Medicine tested whether Azelastine nasal...
Semaglutide — best known as the key ingredient in Ozempic and Wegovy — may be doing more than helping people lose weight. In this video, we dive into new research exploring semaglutide’s unexpected effects on heart health. You’ll hear about a major 2025 study that tested how the drug impacted heart failure symptoms and physical function — and what these findings could mean for people living with obesity and heart conditions.
A new study published in The Lancet evaluated whether semaglutide—the active ingredient in Ozempic and Wegovy—may help more than just weight loss. Researchers found that weekly injections of semaglutide improved heart failure symptoms, physical function, and quality of life in people living with a combination of heart failure and obesity. Why Researchers Are...
A New Approach for Men Whose Cancer Returns Prostate cancer is one of the most common cancers among men. Many patients respond well to initial treatments like surgery or radiation, but some later experience a rise in prostate-specific antigen (PSA) levels which is an early sign that the cancer may be coming back. A new study published in The New England Journal of...
https://www.youtube.com/watch?v=WkYWk3sASYg